Strategies for the treatment of HBV/HDV
- 1 August 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 833, 379-391
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBTNature, 2011
- Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysisVirology Journal, 2011
- Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly AcceleratorsACS Chemical Biology, 2010
- Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor InteractionJournal of Virology, 2010
- Pharmacokinetics of LB80331 and LB80317 following Oral Administration of LB80380, a New Antiviral Agent for Chronic Hepatitis B (CHB), in Healthy Adult Subjects, CHB Patients, and MiceAntimicrobial Agents and Chemotherapy, 2009
- A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2007
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Assembly of Hepatitis Delta Virus: Particle Characterization, Including the Ability To Infect Primary Human HepatocytesJournal of Virology, 2007
- Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface ProteinJournal of Virology, 2005
- Molecular cloning and sequencing of a human hepatitis delta (δ) virus RNANature, 1987